YDES YD Bio (NASDAQ:YDES) is an integrated biotechnology company that combines diagnostics, precision medicine, and regenerative ophthalmology under a single commercial and development strategy. The ...

The new leader has over 20 years of experience leading life science organizations and as a venture capitalist.

AI drug discovery startup Converge Bio raised $25 million in a Series A led by Bessemer Venture Partners, with additional ...

IndyGeneUS Bio today announced the filing of a patent application covering its Clinico-Genomic Insight Enginetm (CGIEtm)?a foundational platform under development to support regulated whole-genome ...

Nautilus’ Iterative Mapping method enables single-molecule analysis of proteins and proteoforms and is designed to achieve comprehensive proteome coverage and detail at scale. The method empowers ...

The Emerging Technologies Conference at Advanced Textiles Expo 2025 explored the importance of textile industry support for innovative ideas.

Syrma Johari’s leadership shared a similar sentiment, noting that the partnership reflects a strong alignment in innovation, quality, and long-term vision, and that it is pleased to support INBS in ...

Dr. Nissan holds a PhD and completed postdoctoral research in the fields of biochemistry and proteomics, from the Weizmann Institute of Science.

Venture capital firm Aditum Bio is going all-out for a new collaboration with Fosun Pharma, launching a subsidiary with the sole purpose of developing novel therapies in tandem with the Shanghai-based ...

WASHINGTON, Dec 18 (Reuters) - White South Africans coming to the U.S. as refugees could get a biography of President Donald Trump for children as part of a welcome packet proposed last week by an ...

MIAMI, Dec. 17, 2025 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes ...